Tramadol Market

Tramadol (INN) is a non-opioid central analgesic that can also bind to opioid receptors, but its affinity is weak, with an affinity for the relative receptors equivalent to 1/6000 of morphine, and only 1/25 of the affinity for and receptors.The drug is synthetic and ACTS on the s-opioid receptors as well as the norepinephrine and serotonin systems.

Tramadol Market contains market size and forecasts of Tramadol (INN) in Global, including the following market information:

Global Tramadol (INN) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tramadol (INN) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Standard Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tramadol (INN) include CSL Limited, Grnenthal GmbH, Mundipharma, Hexal AG, Labopharm, Pliva Pharma, Nippon Shinyaku, Atoz Pharmaceuticals and Rompharm Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Tramadol (INN) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tramadol (INN) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tramadol (INN) Market Segment Percentages, by Type, 2021 (%)

by Standard

Capsule

Injection

Suppositories

Relievers

by Drug-delivery Way

Intravenous

Intramuscular Injection

Subcutaneous Injection

Oral

Anus For Medicine

Global Tramadol (INN) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tramadol (INN) Market Segment Percentages, by Application, 2021 (%)

Pain Relief

Cancer Pain Relief

Labor Pain

Cold Relief

Cough Relief

Global Tramadol (INN) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tramadol (INN) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tramadol (INN) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tramadol (INN) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

CSL Limited

Grnenthal GmbH

Mundipharma

Hexal AG

Labopharm

Pliva Pharma

Nippon Shinyaku

Atoz Pharmaceuticals

Rompharm Company

Amneal Pharmaceuticals

Par Pharmaceutical

Kosher Pharmaceuticals

CSPC

Xinhua Pharmaceutical

Tianlong Shiye

Medochemie

Hubei Qianjiang Pharmaceutical

Shiyao Group

Chenxin Pharmaceutical

Southwest Pharmaceutical

Shandong Xinhua Pharmaceutical

Shanghai Hefeng Pharmaceutical

Duoduo Pharmaceutical

EICARE PHARMACEUTICAL

Guizhou Yikang Pharmaceutical